◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksEHC › Free Cash Flow

Encompass Health Corp (EHC) Free Cash Flow 2006–TTM

DATA UPDATED 2026-09-19

Encompass Health Corp annual free cash flow for fiscal TTM was $414 million, a decrease of 5.7% from $439 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

EHC Annual Free Cash Flow

Free Cash Flow (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Free Cash Flow (FCF)$414M$439M$360M$268M$122M$165M$296M$231M$492M$412M$403M$328M$257M$254M$252M$234M$260M$334M$153M$191M($220M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EHC Quarterly Free Cash Flow

Free Cash Flow (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Free Cash Flow (FCF)$62M$151M$117M$84M$113M$126M$80M$120M$60M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Free Cash Flow at Comparable Companies

More EHC metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding

All EHC financial statements → Interactive EHC charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.